Human breast cancer cell growth inhibition and deregulation of [Ca2+]i by estradiol
Related Experiment Video
Updated: Oct 13, 2026

An Ex vivo Model to Study Hormone Action in the Human Breast
Published on: January 8, 2015
1Department of Pathology, School of Medicine, University of Maryland, Baltimore 21201, USA.
Abstract:
Estradiol inhibits the growth of human breast cancer MCF-7 cells at supramicromolar concentrations. The mechanism of such phenomenon remains to be unravelled. Confocal laser scanning microscopic studies suggest elevation of [Ca2+]i preceding bleb formation and cellular injury following acute and chronic treatment of ionomycin and estradiol at supramicromolar concentration. Phase contrast morphological study demonstrates metaphase-arrested cells and giant multinuclear cells possibly due to lack of cytokinesis caused by estradiol. There is a striking similarity between the morphological changes caused by estradiol and enforced overexpression of cyclin-dependent kinase inhibitor p21waft/cip1. Such similarity together with the reported key role of intracellular ionized calcium [ca2+]i in regulating cyclin and deregulation of [Ca2+]i by estradiol raises the possibility of deregulation of gene expression leading to inhibition of cyclin-dependent proliferative signals participating in inhibition of growth in MCF-7 cells.
Related Concept Videos
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Inhibition of CDK Activity
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

